Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (3968)
All Articles published online
|
Jan 27, 2010 (publication date) through Apr 19, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastrointestinal Surgery
ISSN
1948-9366
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Shimoyama S. Pharmacogenetics of irinotecan: An ethnicity-based prediction of irinotecan adverse events. World J Gastrointest Surg 2010; 2(1): 14-21 [PMID: 21160829 DOI: 10.4240/wjgs.v2.i1.14] |
|---|---|
| URL: | https://www.wjgnet.com/1948-9366/full/v2/i1/14.htm |
| Number | Citing Articles |
| 1 |
|
| 2 |
Cody Lo, Samantha Nguyen, Christine Yang, Lana Witt, Alice Wen, T. Vivian Liao, Jennifer Nguyen, Bryant Lin, Russ B. Altman, Latha Palaniappan. Pharmacogenomics in Asian Subpopulations and Impacts on Commonly Prescribed Medications. Clinical and Translational Science 2020; 13(5): 861 doi: 10.1111/cts.12771
|
| 3 |
Ingrid Fricke-Galindo, Helgi Jung-Cook, Adrián LLerena, Marisol López-López. Interethnic variability of pharmacogenetic biomarkers in Mexican healthy volunteers: a report from the RIBEF (Ibero-American Network of Pharmacogenetics and Pharmacogenomics). Drug Metabolism and Personalized Therapy 2016; 31(2): 61 doi: 10.1515/dmpt-2015-0030
|
| 4 |
M Loh, D Chua, Y Yao, R A Soo, K Garrett, N Zeps, C Platell, T Minamoto, K Kawakami, B Iacopetta, R Soong. Can population differences in chemotherapy outcomes be inferred from differences in pharmacogenetic frequencies?. The Pharmacogenomics Journal 2013; 13(5): 423 doi: 10.1038/tpj.2012.26
|
| 5 |
Mariusz Panczyk. Pharmacogenetics research on chemotherapy resistance in colorectal cancer over the last 20 years. World Journal of Gastroenterology 2014; 20(29): 9775-9827 doi: 10.3748/wjg.v20.i29.9775
|
| 6 |
Jia-Wen Shi, Zhuang-Zhuang Li, Jia-Shuo Wu, Wei-Yi Jin, Xiao-Yan Chang, Hong Sun, Li Dong, Zhi-Ping Jiang, Yue Shi. Identification of the bioactive components of Banxia Xiexin Decoction that protect against CPT-11-induced intestinal toxicity via UPLC-based spectrum-effect relationship analyses. Journal of Ethnopharmacology 2021; 266: 113421 doi: 10.1016/j.jep.2020.113421
|
| 7 |
Chonlaphat Sukasem, Chalirmporn Atasilp, Pichai Chansriwong, Montri Chamnanphon, Apichaya Puangpetch, Ekapob Sirachainan. Development of Pyrosequencing Method for Detection of UGT1A1 Polymorphisms in Thai Colorectal Cancers. Journal of Clinical Laboratory Analysis 2016; 30(1): 84 doi: 10.1002/jcla.21820
|
| 8 |
Dan Liu, Jian Li, Jing Gao, Yanyan Li, Rui Yang, Lin Shen. Examination of multiple UGT1A and DPYD polymorphisms has limited ability to predict the toxicity and efficacy of metastatic colorectal cancer treated with irinotecan-based chemotherapy: a retrospective analysis. BMC Cancer 2017; 17(1) doi: 10.1186/s12885-017-3406-2
|
| 9 |
Nai-Jung Chiang, Tsu-Yi Chao, Ruey-Kuen Hsieh, Cheng-Hsu Wang, Yi-Wen Wang, C. Grace Yeh, Li-Tzong Chen. A phase I dose-escalation study of PEP02 (irinotecan liposome injection) in combination with 5-fluorouracil and leucovorin in advanced solid tumors. BMC Cancer 2016; 16(1) doi: 10.1186/s12885-016-2933-6
|
| 10 |
Miso Kim, Bhumsuk Keam, Tae-Min Kim, Hoon-Gu Kim, Jin-Soo Kim, Sung Sook Lee, Seong Hoon Shin, Min Kyoung Kim, Keon Uk Park, Dong-Wan Kim, Hwan Jung Yun, Jong Seok Lee, Dae Seog Heo. Phase II Study of Irinotecan and Cisplatin Combination Chemotherapy in Metastatic, Unresectable Esophageal Cancer. Cancer Research and Treatment 2017; 49(2): 416 doi: 10.4143/crt.2016.121
|
| 11 |
Edward S Kim, Barbara Melosky, Keunchil Park, Nobuyuki Yamamoto, James C-H Yang. EGFR tyrosine kinase inhibitors for EGFR mutation-positive non-small-cell lung cancer: outcomes in Asian populations. Future Oncology 2021; 17(18): 2395 doi: 10.2217/fon-2021-0195
|
| 12 |
Katsuya Makihara, Sayaka Azuma, Nobuyuki Kawato, Hiroyuki Ueno, Izumi Nakata. Pre-treatment serum total bilirubin level as an indicator of optimal CPT-11 dosage. Cancer Chemotherapy and Pharmacology 2015; 75(2): 273 doi: 10.1007/s00280-014-2633-3
|
| 13 |
Jai N. Patel. Cancer pharmacogenomics. Pharmacogenetics and Genomics 2015; 25(5): 223 doi: 10.1097/FPC.0000000000000134
|
| 14 |
Joanne Siok Liu Lim, Sin Chi Chew, Balram Chowbay. Genomics Applications for the Developing World. Advances in Microbial Ecology 2012; : 183 doi: 10.1007/978-1-4614-2182-5_12
|
| 15 |
Vânia Gaio, Isabel Picanço, Baltazar Nunes, Aida Fernandes, Francisco Mendonça, Filomena Horta Correia, Álvaro Beleza, Ana Paula Gil, Mafalda Bourbon, Astrid Vicente, Carlos Matias Dias, Marta Barreto da Silva. Pharmacogenetic Profile of a South Portuguese Population: Results from the Pilot Study of the European Health Examination Survey in Portugal. Public Health Genomics 2015; 18(3): 139 doi: 10.1159/000373920
|
| 16 |
Dong-Wan Kim, Hoon-Gu Kim, Joo-Hang Kim, Keunchil Park, Hoon-Kyo Kim, Joung Soon Jang, Bong-Seog Kim, Jin-Hyoung Kang, Kyung Hee Lee, Sang-We Kim, Hun Mo Ryoo, Jin-Soo Kim, Ki Hyeong Lee, Jung Hye Kwon, Jin-Hyuk Choi, Sang Won Shin, Seokyung Hahn, Dae Seog Heo. Randomized Phase III Trial of Irinotecan Plus Cisplatin versus Etoposide Plus Cisplatin in Chemotherapy-Naïve Korean Patients with Extensive-Disease Small Cell Lung Cancer. Cancer Research and Treatment 2019; 51(1): 119 doi: 10.4143/crt.2018.019
|
| 17 |
Gábor Rubovszky, Barna Budai, Erna Ganofszky, Zsolt Horváth, Éva Juhos, Balázs Madaras, Tünde Nagy, Eszter Szabó, Tamás Pintér, Erika Tóth, Péter Nagy, István Láng, Erika Hitre. Predictive Value of Early Skin Rash in Cetuximab-Based Therapy of Advanced Biliary Tract Cancer. Pathology & Oncology Research 2018; 24(2): 237 doi: 10.1007/s12253-017-0238-y
|
| 18 |
KOICHI HIROSE, CHIHIRO KOZU, KOSHIRO YAMASHITA, EIJI MARUO, MIZUHO KITAMURA, JUNICHI HASEGAWA, KEI OMODA, TERUO MURAKAMI, YORINOBU MAEDA. Correlation between plasma concentration ratios of SN-38 glucuronide and SN-38 and neutropenia induction in patients with colorectal cancer and wild-type UGT1A1 gene. Oncology Letters 2012; 3(3): 694 doi: 10.3892/ol.2011.533
|
| 19 |
Kyu-pyo Kim, Ho-Sook Kim, Sun Jin Sym, Kyun Seop Bae, Yong Sang Hong, Heung-Moon Chang, Jae Lyun Lee, Yoon-Koo Kang, Jung Shin Lee, Jae-Gook Shin, Tae Won Kim. A UGT1A1*28 and *6 genotype-directed phase I dose-escalation trial of irinotecan with fixed-dose capecitabine in Korean patients with metastatic colorectal cancer. Cancer Chemotherapy and Pharmacology 2013; 71(6): 1609 doi: 10.1007/s00280-013-2161-6
|
| 20 |
Kouichi Hirose, Koushiro Yamashita, Hirofumi Takada, Noriko Kaneda, Kohei Fukami, Eiji Maruo, Mizuho Kitamura, Junichi Hasegawa, Yorinobu Maeda. Usefulness of one-point plasma SN-38G/SN-38 concentration ratios as a substitute for UGT1A1 genetic information after irinotecan administration. International Journal of Clinical Oncology 2014; 19(2): 397 doi: 10.1007/s10147-013-0558-1
|
| 21 |
Tina Trdan Lušin, Robert Roškar, Aleš Mrhar. Evaluation of bisphenol A glucuronidation according to UGT1A1*28 polymorphism by a new LC–MS/MS assay. Toxicology 2012; 292(1): 33 doi: 10.1016/j.tox.2011.11.015
|
| 22 |
Hwi-Yeol Yun, Vincent Chang, Kendra K Radtke, Qianwen Wang, Natasha Strydom, Min Jung Chang, Radojka M Savic. Model-Based Efficacy and Toxicity Comparisons of Moxifloxacin for Multidrug-Resistant Tuberculosis. Open Forum Infectious Diseases 2022; 9(3) doi: 10.1093/ofid/ofab660
|